Does TOCILIZUMAB Cause Polyomavirus-associated nephropathy? 35 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Polyomavirus-associated nephropathy have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.0% of all adverse event reports for TOCILIZUMAB.
35
Reports of Polyomavirus-associated nephropathy with TOCILIZUMAB
0.0%
of all TOCILIZUMAB reports
11
Deaths
9
Hospitalizations
How Dangerous Is Polyomavirus-associated nephropathy From TOCILIZUMAB?
Of the 35 reports, 11 (31.4%) resulted in death, 9 (25.7%) required hospitalization, and 8 (22.9%) were considered life-threatening.
Is Polyomavirus-associated nephropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Polyomavirus-associated nephropathy?
TACROLIMUS (1,477)
MYCOPHENOLATE MOFETIL (1,112)
PREDNISONE (666)
METHYLPREDNISOLONE (416)
PREDNISOLONE (402)
BASILIXIMAB (298)
EVEROLIMUS (247)
CYCLOSPORINE (246)
MYCOPHENOLIC ACID (238)
RITUXIMAB (236)
Which TOCILIZUMAB Alternatives Have Lower Polyomavirus-associated nephropathy Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE